Clinical Trial Update: Follow Up Safety Study of SCH 420814 in Subjects With Parkinson's Disease (P05175) [Phase 2]

View source ↗

Summary

A phase 2 follow-up safety study of SCH 420814 in subjects with Parkinson's disease has completed, with results posted in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• SCH 420814

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Parkinson Disease, Neurodegenerative Diseases | Phase 2 | Status: COMPLETED | Results posted: 2016-12-06